MAPLE-HCM
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM
Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)CompletedOpen NCT05767346 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Loading…